By David Heaney, market development manager (biopharma), Parker Bioscience Filtration
When developing a process for the manufacture of a biopharmaceutical, an R&D or process development team may fall into the trap of developing a process in the lab which is difficult to scale to work with larger volumes in production, leading to delays and costly additional development later on. It is therefore crucial that, where possible, technology is used at small-scale which can be scaled alongside the process in a consistent manner. Taking a thoughtful and strategic approach can help biopharmaceutical products get to market faster and with fewer complications, offering tangible value for stakeholders at all levels.
Fortunately, scalable single-use technologies and automated methodologies make this task more accessible and rewarding than ever. Here are four important steps R&D scientists, production engineers, and other bioprocessing specialists can take to facilitate a smoother and more efficient tech transfer.